Skip to main content
Caplight Logo









Xelcis Bio, Inc.

Xelcis Bio, Inc.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://xelcisbio.com

Company Overview

Xelcis Bio, Inc. operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. It was founded in 2024.

Xelcis Bio, Inc. is a biotechnology company that develops a biocompatible nanoparticle platform for cytosolic delivery of cancer therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Xelcis Bio, Inc. Comparables

Compare Xelcis Bio, Inc. with similar companies based on industry and business-model similarity.

Xelcis Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iDEL Therapeutics
86%
CyGenica
78%
Entos Pharmaceuticals
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Xelcis Bio, Inc. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Xelcis Bio, Inc.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 119% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Xelcis Bio, Inc. Filings

Explore SEC and related filing metadata, where available.

Xelcis Bio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Xelcis Bio, Inc.'s valuation, stock price, and market status.

Is Xelcis Bio, Inc. a public or private company?

Xelcis Bio, Inc. is a private company.

What is the current stock price of Xelcis Bio, Inc.?

Xelcis Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Xelcis Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Xelcis Bio, Inc. worth (valuation)?

Valuation information for Xelcis Bio, Inc. is not publicly available.

Can I buy Xelcis Bio, Inc. stock?

Xelcis Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Xelcis Bio, Inc.'s last funding round?

Funding round information for Xelcis Bio, Inc. is not publicly available.

Who are the main investors in Xelcis Bio, Inc.?

Investor information for Xelcis Bio, Inc. is not publicly disclosed.

Will Xelcis Bio, Inc. IPO soon?

No public IPO plans have been announced for Xelcis Bio, Inc..

How can I track Xelcis Bio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Xelcis Bio, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range4
Year Founded2024
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?